|
|
||||||||
EDITORIAL |
As we close the book on a banner year, I want to present a picture of STEM CELLS remarkable and ongoing growth, and thank those responsible for it.
Nowhere is the currency of STEM CELLS more evident than in our online journal. At about 90,000 views a week, it connects the research world to the papers we publish (figure 1
).
|
The rate of submissions to STEM CELLS has increased 84% over last year (figure 2
) an indicator of the extraordinary growth of the field, and of the currency of our journal. In the midst of this "perfect storm" of submissions, we continue to work toward our goal of less than 30 days average time to first decision for new manuscripts.
|
Another approach to lowering review times is rapid rejection. This mechanism, in which a manuscript deemed to be inappropriate for STEM CELLS does not undergo external review, involves both a Lead Reviewer and a Senior Editor. Its use has increased fourfold in the past year, to the rate of 11% of rejections. The journals acceptance rate is about 46% of submitted manuscripts. It is our intention that rapid rejection benefits the authors of those papers by dramatically decreasing the turnaround time. We are targeting an increase in the use of this mechanism to approximately 20% of rejected manuscripts in 2006.
We also want to provide increased visibility to published papers and authors. The current issue introduces our new covera particularly appealing figure from within the issue, with an explanatory caption at the top of the Table of Contents. This months cover photo is from the article by Yokota et al. (Figure 3
. Bone marrow lacks a transplantable progenitor for smooth muscle type alpha-actin expressing cells. STEM CELLS 2005:24:1322[Medline]).
|
We thank the authors, Editorial Board members, external reviewers, and you, our readers, for making 2005 a banner year for STEM CELLS Journal, and for pledging the energy and dedication needed to carry this remarkable growth to new heights in the coming year.
Curt I. Civin, Editor-in-Chief
Senior Editors:
Alan M. Gewirtz, M.D.
Robert G. Hawley, Ph.D.
Margaret A. Goodell, Ph.D.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
